Merck's molnupiravir has been used in Israel and other countries since late 2021 to treat symptomatic patients with risk factors that could lead to hospitalization or death

AION Labs, a Rehovot-based consortium formed by Pfizer, Merck, AstraZeneca, Teva and others, sets up company that will help drug firms improve chances of success in clinical trials

First shipment expected to arrive in coming days; ministry doesn't specify numbers or price but report says there will be enough for several thousand treatments at $700 a pop

FDA authorizes molnupiravir for combating severe coronavirus infections; will have smaller role than Pfizer's more effective Paxlovid

FDA health advisers narrowly approve medicine by vote of 13-10; treatment set to become first drug Americans can take at home to treat infection

Pharma giants Merck and Pfizer announce encouraging results for oral drugs that largely prevent serious forms of the illness, and hospitalization

British health secretary hails approval of Merck's molnupiravir as a 'historic day,' says country looking to start national study on treatment 'as soon as possible'

Pfizer, Merck, Teva, Amazon form consortium that runs AION Labs, an Israeli facility that will focus on harnessing artificial intelligence in drug development

Bennett reportedly makes announcement to coronavirus cabinet; if cleared, molnupiravir would be 1st pill shown to treat coronavirus patients, a potentially major advance

Pharma giant says will soon seek authorization for the medication's use; if cleared, would be 1st pill shown to treat those infected with virus, a potentially major advance